Can a polypill improve heart-failure treatment?

Combining three heart-failure medicines into one daily capsule improved six-month MRI-measured ejection fraction versus actively optimized separate medicines. Secondary clinical-event findings are encouraging but do not establish a mortality benefit.

Randomized trial · Nature Medicine 2026

Reference: Pandey A, Keshvani N, Rizvi SK, et al. Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial. Nat Med. 2026;32:2933–2940. doi:10.1038/s41591-026-04504-5. PMID:42393373.

Chapters

0:00 Intro

0:38 The trial

3:23 My take

4:01 Outro

Read the structured trial summary at hormoneinsight.com

This podcast is intended for healthcare professionals only. It is educational and is not medical advice. Any views expressed are the presenter's own and do not necessarily reflect the views of any institution he works with.

AI narration disclosure: This episode uses AI-generated narration.

For healthcare professionals. Educational content only; not medical advice or a substitute for clinical judgement, individual assessment or current guidance.

Hormone Insight: https://hormoneinsight.com/

Apple App Store: https://apps.apple.com/sa/app/hormone-insight/id6749515856

Google Play: https://play.google.com/store/apps/details?id=com.fahadwali78.hormoneinsightmobile&hl=en